- Home
- VOR vs TRT Comparison
VOR vs TRT Comparison
Compare VOR & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- TRT
- Stock Information
- Founded
- VOR 2015
- TRT 1958
- Country
- VOR United States
- TRT United States
- Employees
- VOR N/A
- TRT N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- TRT Industrial Machinery/Components
- Sector
- VOR Health Care
- TRT Technology
- Exchange
- VOR Nasdaq
- TRT Nasdaq
- Market Cap
- VOR 22.1M
- TRT 22.5M
- IPO Year
- VOR 2021
- TRT N/A
- Fundamental
- Price
- VOR $0.20
- TRT $5.15
- Analyst Decision
- VOR Buy
- TRT
- Analyst Count
- VOR 6
- TRT 0
- Target Price
- VOR $7.20
- TRT N/A
- AVG Volume (30 Days)
- VOR 5.4M
- TRT 5.7K
- Earning Date
- VOR 05-14-2025
- TRT 05-13-2025
- Dividend Yield
- VOR N/A
- TRT N/A
- EPS Growth
- VOR N/A
- TRT N/A
- EPS
- VOR N/A
- TRT 0.00
- Revenue
- VOR N/A
- TRT $35,548,000.00
- Revenue This Year
- VOR N/A
- TRT N/A
- Revenue Next Year
- VOR N/A
- TRT N/A
- P/E Ratio
- VOR N/A
- TRT $1,169.00
- Revenue Growth
- VOR N/A
- TRT N/A
- 52 Week Low
- VOR $0.13
- TRT $4.62
- 52 Week High
- VOR $1.80
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- VOR 26.80
- TRT 48.61
- Support Level
- VOR $0.17
- TRT $4.62
- Resistance Level
- VOR $0.20
- TRT $5.32
- Average True Range (ATR)
- VOR 0.03
- TRT 0.21
- MACD
- VOR 0.02
- TRT 0.02
- Stochastic Oscillator
- VOR 38.76
- TRT 49.53
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.